Actinic Keratosis Clinical Trials

233 clinical trials for Actinic Keratosis across international registries, including 14 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• An Open-Label Pharmacokinetic Study for Patients With Actinic Keratosis on the Upper Extremities or the Face — RECRUITING · PHASE1
• Outcomes Associated With Tirbanibulin for Large Field Application on the Face in the U.S (CLEAR) — RECRUITING
• A Randomized Controlled Trial of Topical 5% Niacinamide for Skin Cancer Prevention in Transplant Recipients — RECRUITING · PHASE1
• Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Face and Scalp — RECRUITING · PHASE3
• Study of Reformulated Levulan Kerastick Plus PDT for Actinic Keratosis on Upper Extremities — RECRUITING · PHASE3
• Study of the Photoprotection and Prevention of Actinic Damage With Anthelios Fluide 100 KA+ UVMune 400 in Patients With Multiple Actinic Keratoses — RECRUITING · NA
• A Phase Ib Study of HW211026 Ointment in Patients With Actinic Keratosis. — RECRUITING · PHASE1
• The Effect of Topical Imipramine on Photodynamic Therapy-Mediated Immunosuppression on Forearms or Face on US Veterans — RECRUITING · PHASE2
• Investigation of the Efficacy and Tolerability of Topical Applied Tirbanibulin on Actinic Keratoses With Downward-directed Proliferation Patterns — RECRUITING
• An exploratory, multicenter, randomized, open-label with blind evaluation, active-controlled study to evaluate the safety and efficacy of Keramod® (imiquimod 50 mg/g, Gel) compared with Aldara® (imiquimod 50 mg/g, Cream) for the treatment of actinic keratosis in adults. — RECRUITING · PHASE2
• The Effect of Topical Imipramine on Pain and Effectiveness of Topical Photodynamic Therapy — RECRUITING · PHASE1
• EFFICACY AND SAFETY OF INGENOL MEBUTATE GEL IN FIELD TREATMENT OF ACTINIC KERATOSIS ON FULL FACE, BALDING SCALP OR APPROXIMATELY 250 CM2 ON THE CHEST — RECRUITING
• SAFETY AND EFFICACY OF ESCALATING DOSES OF LEO 43204 APPLIED ONCE DAILY FOR TWO CONSECUTIVE DAYS ON APPROXIMATELY 250 CM2 ON TRUNK AND EXTREMITIES IN SUBJECTS WITH ACTINIC KERATOSIS. PART 2 (CANADA): A PHASE 2, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP, VEHICLE-CONTROLLED, 8-WEEK TRIAL — RECRUITING · PHASE2
• LEO SAFETY AND EFFICACY OF ESCALATING DOSES OF TWO LEO 43204 FORMULATIONS APPLIED ONCE DAILY FOR TWO CONSECUTIVE DAYS ON FULL FACE OR APPROXIMATELY 250 CM2 (40 IN2) ON THE CHEST IN SUBJECTS WITH ACTINIC KERATOSIS; PART 2: A PHASE 2, MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PARALLEL GROUP, VEHICLE-CONTROLLED, 8-WEEK TRIAL OF LEO 43204 GEL IN SUBJECTS WITH AK (CANADA AND US) — RECRUITING · PHASE2
• Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis (sun spots) on Face or Chest including 12-month follow-up — COMPLETED · PHASE3
• A Randomised Cross-Over Study to Explore the Pathophysiological Mechanisms Involved in the Treatment of Actinic Keratoses with Solaraze — COMPLETED · PHASE4
• Vergleich eines bekannten Arzneimittels zur Behandlung der aktinischen Keratose (eine durch langzeitige Sonneneinwirkung hervorgerufene Hauterkrankung) mit einem neuen Arzneimittel (mit gleichem Wirkstoff) und der Grundlage ohne Wirkstoff. — COMPLETED · PHASE3
• Clinical trial to investigate clinical efficacy and tolerability of Tretinoin in actinic keratosis — COMPLETED · PHASE2
• Characterisation of count of actinic keratosis during treatment with zyclara by non-invasive study with high definition optical coherence tomography (HD-OCT) and reflectance confocal microscopy (RCM) — COMPLETED · PHASE3
• Clinical effectiveness and effect on COX-2 expression of the sequential treatment of actinic keratoses (AK) with photodynamic therapy (PDT) and diclofenac 3% gel: a phase IV clinical trial — ACTIVE_NOT_RECRUITING · PHASE4
• Skin cancer prevention in people who have had organ transplants by the use of treatment creams to get rid of actinic keratosis skin lesions (cancer precursors)- does this work? — COMPLETED · PHASE2
• Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis (sun spots) on Balding Scalp including 12-month follow-up — COMPLETED · PHASE3
• Investigation of the effective and safe use of the drug product in the treatment of actinic keratosis with daylight — COMPLETED · PHASE3
• Investigation of the effective and safe use of the drug product in the treatment of actinic keratosis on extremities and trunk/neck. — COMPLETED · PHASE3
• A prospective comparator controlled randomized exploratory study on the efficacy of LAS 41005 compared to cryotherapy in subjects with hyperkeratotic actinic keratosis — COMPLETED · PHASE2
• Evaluate RLS-1496 Topical Cream for Actinic Keratosis — ACTIVE_NOT_RECRUITING · PHASE1
• A Phase 4, Multi-centre, Randomized, Evaluator-blinded, Active-controlled Study to Determine the Incidence of Squamous Cell Carcinoma and Evaluate the Long-term Safety of Tirbanibulin 10 mg/g Ointment and Diclofenac Sodium 3% Gel for the Treatment of Adult Patients With Actinic Keratosis on the Face or Scalp — TERMINATED · PHASE4
• A Phase 2 Study of HW211026 — NOT_YET_RECRUITING · PHASE2
• Therapeutic Induction of Dermal Remodeling in Veterans to Prevent Actinic Neoplasia Caused by Chronic Environmental Exposure to Ultraviolet Radiation — NOT_YET_RECRUITING · NA
• Prospective, multistage, two-arm, randomised, double-blind study on the efficacy and safety of treatment of mild to moderate actinic keratosis with a 5% potassium hydroxide solution versus placebo with different duration of treatment cycles — TERMINATED · PHASE3
• Combination therapy of 5-Fluorouracil and Calcipotriol versus 5-Fluorouracil in the treatment of Actinic Keratosis: a multicentre randomized controlled clinical trial — TERMINATED · PHASE4
• Trial to Investigate GZ21T in Healthy Volunteers — COMPLETED · PHASE1
• Indoor Daylight Photodynamic Therapy is an Effective, First-line Treatment for AK, But Its Feasibility is Limited by the Time Required for the Illumination (2 Hours). Our Objective Was to Evaluate the Efficacy of Idl-PDT With an Illumination Time of 1 Hour Versus 2 Hours in the Treatment of Scalp AK — COMPLETED · NA
• Double-blind, Placebo-Controlled, Randomized Exploratory Trial: Topical VDA-1102 Ointment in Rapidly Proliferating Actinic Keratosis — TERMINATED · PHASE2
• Short Contact Protocols to Reduce Pain During 10% ALA Gel Red-light Photodynamic Therapy of Actinic Keratoses — COMPLETED · PHASE2
• Testing the Efficacy of Topical Calcipotriene Plus 5-Fluorouracil Combination to Activate the Immune System Against Precancerous Skin Lesions in Organ Transplant Recipients — ACTIVE_NOT_RECRUITING · PHASE2
• Study on the Safety and Efficacy of Bimiralisib Gel in Participants Suffering From Actinic Keratosis — COMPLETED · PHASE2
• Photodynamic Therapy (PDT) With Metvix® 160 Milligrams/Gram Cream in Organ Transplant Participants With Non-melanoma Skin Cancer — COMPLETED · PHASE3
• Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up — COMPLETED · PHASE3
• Safety and Efficacy of Ingenol Mebutate Once Daily for 2 or 3 Consecutive Days in Subjects With Actinic Keratosis — COMPLETED · PHASE1
• A Trial to Compare the Incidence of Squamous Cell Carcinoma (SCC) and Other Skin Neoplasia on Skin Areas Treated With Ingenol Disoxate Gel or Vehicle Gel for Actinic Keratosis on Face and Chest or Scalp — TERMINATED · PHASE3
• Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis — COMPLETED · PHASE2
• Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest — COMPLETED · PHASE3
• A Sequential Treatment Regimen of Cryotherapy and Picato® for the Treatment of Actinic Keratosis on the Face and Scalp — COMPLETED · PHASE3
• Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Face or Chest Including 12-month Follow-up — COMPLETED · PHASE3
• Efficacy and Safety of LEO 43204 in Field Treatment of Actinic Keratosis on Balding Scalp Including 12-month Follow-up — COMPLETED · PHASE3
• Ingenol Mebutate Gel, 0.015% Repeat Use for Multiple Actinic Keratoses on Face and Scalp — COMPLETED · PHASE3
• Safety of LEO 43204 for Actinic Keratosis Applied on Face/Chest, Scalp and Trunk/Extremities, Respectively — COMPLETED · PHASE2
• Efficacy and Safety of LEO 43204 in the Field Treatment of Actinic Keratosis on Face or Chest including12-month Follow-up — COMPLETED · PHASE3
• PEP005 Gel - Biological Effects in Actinic Keratosis Assessed by Reflectance Confocal Microscopy — COMPLETED · PHASE1

Refine this search